153 related articles for article (PubMed ID: 1455176)
1. Substrate specificity and inhibitors of aspartic proteinases.
Kay J; Dunn BM
Scand J Clin Lab Invest Suppl; 1992; 210():23-30. PubMed ID: 1455176
[TBL] [Abstract][Full Text] [Related]
2. Active-site specificity of digestive aspartic peptidases from the four species of Plasmodium that infect humans using chromogenic combinatorial peptide libraries.
Beyer BB; Johnson JV; Chung AY; Li T; Madabushi A; Agbandje-McKenna M; McKenna R; Dame JB; Dunn BM
Biochemistry; 2005 Feb; 44(6):1768-79. PubMed ID: 15697202
[TBL] [Abstract][Full Text] [Related]
3. X-ray structures of five renin inhibitors bound to saccharopepsin: exploration of active-site specificity.
Cronin NB; Badasso MO; J Tickle I; Dreyer T; Hoover DJ; Rosati RL; Humblet CC; Lunney EA; Cooper JB
J Mol Biol; 2000 Nov; 303(5):745-60. PubMed ID: 11061973
[TBL] [Abstract][Full Text] [Related]
4. Multidisciplinary cycles for protein engineering: site-directed mutagenesis and X-ray structural studies of aspartic proteinases.
Pitts JE; Dhanaraj V; Dealwis CG; Mantafounis D; Nugent P; Orprayoon P; Cooper JB; Newman M; Blundell TL
Scand J Clin Lab Invest Suppl; 1992; 210():39-50. PubMed ID: 1455178
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin.
Fujimoto Z; Fujii Y; Kaneko S; Kobayashi H; Mizuno H
J Mol Biol; 2004 Aug; 341(5):1227-35. PubMed ID: 15321718
[TBL] [Abstract][Full Text] [Related]
6. Engineering the substrate specificity of rhizopuspepsin: the role of Asp 77 of fungal aspartic proteinases in facilitating the cleavage of oligopeptide substrates with lysine in P1.
Lowther WT; Majer P; Dunn BM
Protein Sci; 1995 Apr; 4(4):689-702. PubMed ID: 7613467
[TBL] [Abstract][Full Text] [Related]
7. Evaluations of substrate specificity and inhibition at PR/p3 cleavage site of HTLV-1 protease.
Naka H; Teruya K; Bang JK; Aimoto S; Tatsumi T; Konno H; Nosaka K; Akaji K
Bioorg Med Chem Lett; 2006 Jul; 16(14):3761-4. PubMed ID: 16682197
[TBL] [Abstract][Full Text] [Related]
8. X-ray analyses of aspartic proteinases. V. Structure and refinement at 2.0 A resolution of the aspartic proteinase from Mucor pusillus.
Newman M; Watson F; Roychowdhury P; Jones H; Badasso M; Cleasby A; Wood SP; Tickle IJ; Blundell TL
J Mol Biol; 1993 Mar; 230(1):260-83. PubMed ID: 8450540
[TBL] [Abstract][Full Text] [Related]
9. Primary structure of a precursor to the aspartic proteinase from Rhizomucor miehei shows that the enzyme is synthesized as a zymogen.
Boel E; Bech AM; Randrup K; Draeger B; Fiil NP; Foltmann B
Proteins; 1986 Dec; 1(4):363-9. PubMed ID: 3329734
[TBL] [Abstract][Full Text] [Related]
10. Domain flexibility in aspartic proteinases.
Sali A; Veerapandian B; Cooper JB; Moss DS; Hofmann T; Blundell TL
Proteins; 1992 Feb; 12(2):158-70. PubMed ID: 1603805
[TBL] [Abstract][Full Text] [Related]
11. Modeling of substrate specificity of the Alzheimer's disease amyloid precursor protein beta-secretase.
Sauder JM; Arthur JW; Dunbrack RL
J Mol Biol; 2000 Jul; 300(2):241-8. PubMed ID: 10873463
[TBL] [Abstract][Full Text] [Related]
12. Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors.
Savarino A; Cauda R; Cassone A
J Infect Dis; 2005 Apr; 191(8):1381-2; author reply 1382-3. PubMed ID: 15776390
[No Abstract] [Full Text] [Related]
13. Comparative properties of feline immunodeficiency virus (FIV) and human immunodeficiency virus type 1 (HIV-1) proteinases prepared by total chemical synthesis.
Schnölzer M; Rackwitz HR; Gustchina A; Laco GS; Wlodawer A; Elder JH; Kent SB
Virology; 1996 Oct; 224(1):268-75. PubMed ID: 8862421
[TBL] [Abstract][Full Text] [Related]
14. Structure-function database for active site binding to the aspartic proteinases.
Rao C; Scarborough PE; Lowther WT; Kay J; Batley B; Rapundalo S; Klutchko S; Taylor MD; Dunn BM
Adv Exp Med Biol; 1991; 306():143-7. PubMed ID: 1812702
[No Abstract] [Full Text] [Related]
15. [Mechanism of action of aspartic proteases. IV.Conformational characteristics of a substrate and an inhibitor of rhizopuspepsin ].
Kashparov IV; Popov ME; Popov EM
Bioorg Khim; 1999 Jun; 25(6):423-34. PubMed ID: 10505230
[TBL] [Abstract][Full Text] [Related]
16. Substrates and inhibitors of human T-cell leukemia virus type I protease.
Ding YS; Rich DH; Ikeda RA
Biochemistry; 1998 Dec; 37(50):17514-8. PubMed ID: 9860866
[TBL] [Abstract][Full Text] [Related]
17. The selectivity of statine-based inhibitors against various human aspartic proteinases.
Jupp RA; Dunn BM; Jacobs JW; Vlasuk G; Arcuri KE; Veber DF; Perlow DS; Payne LS; Boger J; de Laszlo S
Biochem J; 1990 Feb; 265(3):871-8. PubMed ID: 2407237
[TBL] [Abstract][Full Text] [Related]
18. Cleavage efficiency of the novel aspartic protease yapsin 1 (Yap3p) enhanced for substrates with arginine residues flanking the P1 site: correlation with electronegative active-site pockets predicted by molecular modeling.
Olsen V; Guruprasad K; Cawley NX; Chen HC; Blundell TL; Loh YP
Biochemistry; 1998 Mar; 37(9):2768-77. PubMed ID: 9485427
[TBL] [Abstract][Full Text] [Related]
19. Macrocyclic statine-based inhibitors of BACE-1.
Barazza A; Götz M; Cadamuro SA; Goettig P; Willem M; Steuber H; Kohler T; Jestel A; Reinemer P; Renner C; Bode W; Moroder L
Chembiochem; 2007 Nov; 8(17):2078-91. PubMed ID: 17963207
[TBL] [Abstract][Full Text] [Related]
20. The activity and inhibition of the food vacuole plasmepsin from the rodent malaria parasite Plasmodium chabaudi.
Martins TM; Domingos A; Berry C; Wyatt DM
Acta Trop; 2006 Feb; 97(2):212-8. PubMed ID: 16329985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
